Financial results - SYNERGA PHARMACEUTICALS S.R.L.

Financial Summary - Synerga Pharmaceuticals S.r.l.
Unique identification code: 22842646
Registration number: J23/3266/2007
Nace: 4646
Sales - Ron
22.903
Net Profit - Ron
-172.772
Employees
1
Open Account
Company Synerga Pharmaceuticals S.r.l. with Fiscal Code 22842646 recorded a turnover of 2023 of 22.903, with a net profit of -172.772 and having an average number of employees of 1. The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Synerga Pharmaceuticals S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 38.696 40.401 37.932 39.010 724.522 906.022 1.003.858 9.846 23.032 -
Total Income - EUR 38.696 40.401 37.932 39.010 727.984 912.998 1.008.773 19.854 32.327 -
Total Expenses - EUR 28.975 31.937 29.837 11.104 606.399 758.041 827.257 319.756 206.070 -
Gross Profit/Loss - EUR 9.721 8.464 8.095 27.906 121.585 154.956 181.516 -299.902 -173.743 -
Net Profit/Loss - EUR 8.560 7.207 6.957 26.736 114.337 147.255 171.995 -299.902 -173.743 -
Employees 1 0 0 0 4 9 3 1 1 -
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 134.6%, from 9.846 euro in the year 2022, to 23.032 euro in 2023.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Synerga Pharmaceuticals S.r.l.

Rating financiar

Financial Rating -
SYNERGA PHARMACEUTICALS S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Synerga Pharmaceuticals S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Synerga Pharmaceuticals S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Synerga Pharmaceuticals S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Synerga Pharmaceuticals S.r.l. - CUI 22842646

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 8.918 9.445 8.600 9.093 51.108 50.244 44.513 13.044 14.886 -
Current Assets 1.905 1.603 1.256 4.826 712.642 726.666 539.866 258.718 118.826 -
Inventories 0 0 0 0 76.085 312.794 68.884 32.220 17.031 -
Receivables 3.421 1.533 1.246 4.792 580.210 213.479 44.688 29.236 101.737 -
Cash -1.517 70 10 34 56.347 200.393 426.294 106.013 58 -
Shareholders Funds -38.872 -31.269 -23.783 3.562 117.893 206.829 227.152 -72.045 -245.569 -
Social Capital 45 45 44 215 274 269 263 264 263 -
Debts 49.781 42.403 33.723 10.358 645.856 570.081 357.226 345.310 379.331 -
Income in Advance 0 0 0 0 0 0 0 0 0 -
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 118.826 euro in 2023 which includes Inventories of 17.031 euro, Receivables of 101.737 euro and cash availability of 58 euro.
The company's Equity was valued at -245.569 euro, while total Liabilities amounted to 379.331 euro. Equity decreased by -173.743 euro, from -72.045 euro in 2022, to -245.569 in 2023.

Risk Reports Prices

Reviews - Synerga Pharmaceuticals S.r.l.

Comments - Synerga Pharmaceuticals S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.